A new study published in the journal of BMC Surgery found that marginal ulcers occurred at a relatively high rate following ...

Glucagon-like peptide-1 receptor agonist use increased among eligible patients while metabolic and bariatric surgery rates declined.

A study in Gut shows that gastric cancer is shaped by complex interactions between environmental exposure, microbes, host, ...

Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

From 2023, there was a decrease in use of metabolic and bariatric surgery, with stronger decline for sleeve gastrectomy.

Multiple randomized clinical trials now show that type 2 diabetes can be pushed into remission through structured weight loss ...

This article highlights the importance of recognizing obesity as a complex metabolic disease requiring structured medical care, such as bariatric surgery. A patient's journey illustrates how such ...

Amylyx Pharmaceuticals (NASDAQ:AMLX) executives told investors the company entered 2026 with a focus on advancing avexitide toward what could become the first FDA-approved therapy for post-bariatric ...

Heterotopic gastric mucosa of the proximal esophagus (HGMPE) is a congenital island of salmon-colored, abnormally located gastric epithelium, commonly present distally to the upper esophageal ...

Diet lays the metabolic groundwork, injections offer pharmacological support, surgery delivers powerful physiological change, but long-term results demand behavioural restructuring ...

A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.